These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8999002)

  • 1. [Pathogenicity of fungi in the intestines--current status of the discussion].
    Scheurlen M
    Fortschr Med; 1996 Sep; 114(26):319-21. PubMed ID: 8999002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Intestinal mycoses--do they exist?].
    Hof H
    Leber Magen Darm; 1993 Sep; 23(5):184-5. PubMed ID: 8412466
    [No Abstract]   [Full Text] [Related]  

  • 3. [Fungi in the oro-intestinal tract and their scientifically founded status].
    Knoke M
    Z Arztl Fortbild Qualitatssich; 1998 Apr; 92(3):157-62. PubMed ID: 9606881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Normal findings or disease? Fungi in the bowel].
    Rösch WW
    MMW Fortschr Med; 2003 Jul; 145(27-28):10. PubMed ID: 14587178
    [No Abstract]   [Full Text] [Related]  

  • 5. [How dangerous is Candida in the intestine? The great fungal business].
    Stiefelhagen P
    MMW Fortschr Med; 2000 Jul; 142(28-29):4-6. PubMed ID: 10959151
    [No Abstract]   [Full Text] [Related]  

  • 6. [Fungal infection of the small bowel mucosa].
    Lorenz A; Grütte FK; Schön E; Müller B; Klimmt G
    Mykosen; 1984 Oct; 27(10):506-10. PubMed ID: 6392882
    [No Abstract]   [Full Text] [Related]  

  • 7. [Recommendations of the Robert Koch Institute. Pathogenetic significance of intestinal candida colonization. Report of the "Methods and Quality Assurance in Environmental Medicine" Committee of the Robert Koch Institute].
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2004 Jun; 47(6):587-600. PubMed ID: 15221111
    [No Abstract]   [Full Text] [Related]  

  • 8. [Fungal involvement of the intestinal tract in HIV-positive males].
    Gallenkemper G; Kuhlwein A
    Z Hautkr; 1988 Apr; 63(4):336-7. PubMed ID: 3291443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pseudomonas aeruginosa and Candida albicans interaction in the respiratory tract: from pathophysiology to a therapeutic perspective].
    Ader F; Faure K; Guery B; Nseir S
    Pathol Biol (Paris); 2008 May; 56(3):164-9. PubMed ID: 17905537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fungal infection after antibiotic therapy (author's transl)].
    Müller J
    MMW Munch Med Wochenschr; 1976 May; 118(21):669-72. PubMed ID: 818546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fungal colonization and invasive fungal infections following allogeneic BMT using metronidazole, ciprofloxacin and fluconazole or ciprofloxacin and fluconazole as intestinal decontamination.
    Trenschel R; Peceny R; Runde V; Elmaagacli A; Dermoumi H; Heintschel von Heinegg E; Müller KD; Schaefer UW; Beelen DW
    Bone Marrow Transplant; 2000 Nov; 26(9):993-7. PubMed ID: 11100279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of the Porcine Intestinal Epithelium (PIE)-Assay to analyze early stages of colonization by the human fungal pathogen Candida albicans.
    Wendland J; Hellwig D; Walther A; Sickinger S; Shadkchan Y; Martin R; Bauer J; Osherov N; Tretiakov A; Saluz HP
    J Basic Microbiol; 2006; 46(6):513-23. PubMed ID: 17139615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Serotyping of strains of Candida albicans isolated from children with acute lymphoid leukemia].
    Budak A; Trojanowska D; Pekacki A
    Med Dosw Mikrobiol; 1988; 40(3):161-6. PubMed ID: 3073280
    [No Abstract]   [Full Text] [Related]  

  • 14. Candida dubliniensis, a new fungal pathogen.
    Gutiérrez J; Morales P; González MA; Quindós G
    J Basic Microbiol; 2002; 42(3):207-27. PubMed ID: 12111748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intestinal candidiasis. A clinical report and comments about this opportunistic pathology.
    Ruiz-Sánchez D; Calderón-Romero L; Sánchez-Vega JT; Tay J
    Mycopathologia; 2002; 156(1):9-11. PubMed ID: 12715941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced pathogenicity of Candida albicans pre-treated with subinhibitory concentrations of fluconazole in a mouse model of disseminated candidiasis.
    Navarathna DH; Hornby JM; Hoerrmann N; Parkhurst AM; Duhamel GE; Nickerson KW
    J Antimicrob Chemother; 2005 Dec; 56(6):1156-9. PubMed ID: 16239285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human fungal pathogen Candida albicans in the postgenomic era: an overview.
    Kabir MA; Hussain MA
    Expert Rev Anti Infect Ther; 2009 Feb; 7(1):121-34. PubMed ID: 19622061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Candida albicans pathogenicity: a proteomic perspective.
    Niimi M; Cannon RD; Monk BC
    Electrophoresis; 1999 Aug; 20(11):2299-308. PubMed ID: 10493133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America.
    Rex JH; Walsh TJ; Sobel JD; Filler SG; Pappas PG; Dismukes WE; Edwards JE
    Clin Infect Dis; 2000 Apr; 30(4):662-78. PubMed ID: 10770728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular organization of the cell wall of Candida albicans and its relation to pathogenicity.
    Ruiz-Herrera J; Elorza MV; Valentín E; Sentandreu R
    FEMS Yeast Res; 2006 Jan; 6(1):14-29. PubMed ID: 16423067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.